Search Results 671-680 of 18093 for Tuberculosis

1. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   - Has a known history of active tuberculosis (TB). - Gastrointestinal disorder that may impact absorption of oral medications. - History of solid organ or ...

2. Combination Study of SV-BR-1-GM in Combination With INCMGA00012 and Retifanlimab - Mayo Clinic

   Has a known history of active tuberculosis (TB; Bacillus tuberculosis). Patients with severe psychiatric (e.g., schizophrenia, bipolar, or borderline ...

3. A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 In Healthy Participants And Participants With Mild-to-Moderate Asthma - Mayo Clinic

   * History of tuberculosis (TB), TB symptoms, or positive interferon gamma release assay. * History of untreated or unresolved helminthic infection within 24 ...

4. 24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry - Mayo Clinic

   Tuberculosis; Fungal infections; Excessive exogenous calcium or vitamin D intake. Participating Mayo Clinic locations. Study statuses change often. Please ...

5. Drug Combo Shuts Down Stem Cells, Tumor Growth in Lung Cancer - Mayo Clinic News Network

   Mayo Clinic Radio: Getting Enough Sleep / Tuberculosis Update / New Lyme Disease Bacterium. Related Articles. Surgery plays a central role in treatment for ...

6. Indinavir (oral route) - Side effects & dosage - Mayo Clinic

   When you start taking HIV medicines, your immune system may get stronger. If you have infections that are hidden in your body, such as pneumonia or tuberculosis ...

7. Publications - Gui Piovezani Ramos, M.D. - Mayo Clinic

   Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy. Inflamm Bowel Dis. 2018 Sep ...

8. Clinical Trials - Autoimmunity in the Pathogenesis of AF

   ... tuberculosis, periodontitis, non-healing wounds, dermatitis). Recent malignancies (in the past two years). Radiation or chemotherapy (in the past two years) ...

9. A Phase III, Randomised Study Of Adjuvant Dato-DXd In Combination With Rilvegostomig Or Rilvegostomig Monotherapy Versus Standard Of Care, Following Complete Tumour Resection, In Participants With Stage I Adenocarcinoma NSCLC Who Are CtDNA-positive Or Have High-risk Pathological Features - Mayo Clinic

   Active infection with tuberculosis, hepatitis B or C virus, hepatitis A, or known HIV infection that is not well controlled 8. History of active primary ...

10. A Study to Evaluate Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants with Moderate-to-Severe Allergic Asthma - Mayo Clinic

    Active tuberculosis requiring treatment within 12 months prior to screening: Patients who have completed treatment for tuberculosis at least 12 months ...